Your browser doesn't support javascript.
Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine.
Sapkal, Gajanan; Yadav, Pragya D; Ella, Raches; Abraham, Priya; Patil, Deepak Y; Gupta, Nivedita; Panda, Samiran; Mohan, V Krishna; Bhargava, Balram.
  • Sapkal G; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India.
  • Yadav PD; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India.
  • Ella R; Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India.
  • Abraham P; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India.
  • Patil DY; Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India.
  • Gupta N; Indian Council of Medical Research, New Delhi, India.
  • Panda S; Indian Council of Medical Research, New Delhi, India.
  • Mohan VK; Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India.
  • Bhargava B; Indian Council of Medical Research, New Delhi, India.
J Travel Med ; 28(7)2021 10 11.
Article in English | MEDLINE | ID: covidwho-1462384
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal subject: Communicable Diseases / Public Health Year: 2021 Document Type: Article Affiliation country: Jtm

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal subject: Communicable Diseases / Public Health Year: 2021 Document Type: Article Affiliation country: Jtm